PRTN3 and rheumatoid arthritis: CCP+ at-risk individuals can be identified by the screening of first-degree relatives (FDRs) of individuals with RA, for whom the heritability of RA is approximately 20% if ACPA negative or up to 50% if ACPA positive [35].